CEO-TWO
- Product NDC
- 0283-1023
- 11-digit product format
- 002831023
- Labeler code
- 0283
- Product ID
- 0283-1023_42e0774e-b617-290d-e063-6394a90a199e
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Laxative
- Dosage form
- SUPPOSITORY
- Route
- RECTAL
- Labeler
- Beutlich Pharmaceuticals, LLC
- Application
- M007
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2023-10-15
- Substance
- POTASSIUM BITARTRATE; SODIUM BICARBONATE
- Active strength
- .9; .6 g/5.7g; g/5.7g
- Pharmacologic classes
- Alkalinizing Activity [MoA], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- CEO-TWO
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| POTASSIUM BITARTRATE | .9 g/5.7g |
| SODIUM BICARBONATE | .6 g/5.7g |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| NPT6P8P3UU | Internal UNII lookup |
| 8MDF5V39QO | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 08670636-5795-4db0-e063-6294a90afa4b | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0283-1023-00 | CEO-TWO | 5.7 g in 1 DOSE PACK | SUPPOSITORY | 5.7 | 3 | |
| 0283-1023-02 | CEO-TWO | 2 in 1 BOX | SUPPOSITORY | 2 | 3 | |
| 0283-1023-36 | CEO-TWO | 6 in 1 BOX | SUPPOSITORY | 6 | 3 | |
| 0283-1023-54 | CEO-TWO | 54 in 1 BOX | SUPPOSITORY | 54 | 3 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0283-1023-02 | EA - Each | 0283-1023 | d7803fbb-22f6-4acb-bdd2-b3da0cb16667 | 1 | 2025-08-11 |
| 0283-1023-36 | EA - Each | 0283-1023 | 299afce1-70d3-4bcd-88c0-094182298613 | 1 | 2025-08-11 |
| 0283-1023-54 | EA - Each | 0283-1023 | aab567b9-183d-4296-a18e-a6c0a9c6cd3e | 1 | 2025-08-11 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Publix Fiber Therapy Sugar Free | PSYLLIUM HUSK | PUBLIX SUPER MARKETS, INC | ed3dc80a-a243-4013-9886-b148e3e3b662 | 2025-10-28 | Warnings | M007 |
| Childrens Oral Saline Laxative | MAGNESIUM HYDROXIDE | WAL-MART STORES,INC., | a2eb50ab-851a-4abb-a12f-6d9d8b0cb6bc | 2025-10-27 | Warnings | M007 |
| equate Fiber Therapy | METHYLCELLULOSE | Wal-Mart Stores,Inc., | 7acc30b4-e946-42cd-8eec-cf15159d478d | 2025-10-27 | Warnings | M007 |
| Glycerin | GLYCERIN | DSC Laboratories Inc. | 5e97aa5b-62e2-0664-e053-2a91aa0ac341 | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | H E B | 3d03ce42-e671-6d76-e054-00144ff8d46c | 2025-10-24 | Warnings | M007 |
| Bisacodyl | BISACODYL | CVS Pharmacy | c56e010a-7503-3e1c-e053-2a95a90a2b85 | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | Chain Drug Consortium LLC | 022dd494-cb3c-4fa7-be99-4c38fabdc612 | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | DSC Laboratories Inc. | 5e97c4d2-e41d-5bb6-e053-2a91aa0a3163 | 2025-10-24 | Warnings | M007 |
| Bisacodyl | BISACODYL | Major Pharmaceuticals | c194c40c-c732-2f03-e053-2a95a90a7a40 | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | CVS Pharmacy | 94e4a6f3-43d0-b2a5-e053-2a95a90aa115 | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | Chain Drug Marketing Association Inc. | 5e83d3ef-91c5-1c3a-e053-2a91aa0a93ed | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | Rite Aid Corporation | 5da2ea79-f3bc-b82b-e053-2a91aa0af0af | 2025-10-24 | Warnings | M007 |
| Bisacodyl | BISACODYL | Pharmacy Value Alliance LLC | 8a6d6729-f6eb-4f68-e053-2a95a90a5c9e | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | Rite Aid Corporation | 5da2ea79-f37a-b82b-e053-2a91aa0af0af | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | DSC Laboratories Inc. | a381838b-d1ae-11c5-e053-2a95a90a7bcb | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | Amerisource Bergen/Good Neighbor Pharmacy | 90a4d385-d548-420b-91d2-54d5e819fcce | 2025-10-24 | Warnings | M007 |
| Bisacodyl | BISACODYL | Cardinal Health | c2b33e78-6ab7-1785-e053-2995a90a9c4f | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | CVS Pharmacy | 3a59c4a9-5f86-406a-e054-00144ff8d46c | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | Cardinal Health | 7e7e9366-af1e-e0ff-e053-2a91aa0a9487 | 2025-10-24 | Warnings | M007 |
| Glycerin | GLYCERIN | Cardinal Health | c2b02afc-5a8a-2a25-e053-2a95a90ae45c | 2025-10-24 | Warnings | M007 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 636188 | CEO-TWO 0.9 GM / 0.6 GM Rectal Suppository | PSN | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
| 636185 | potassium bitartrate 0.9 GM / sodium bicarbonate 0.6 GM Rectal Suppository | PSN | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
| 636188 | potassium bitartrate 900 MG / sodium bicarbonate 600 MG Rectal Suppository [Ceo-Two] | SBD | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
| 636185 | potassium bitartrate 900 MG / sodium bicarbonate 600 MG Rectal Suppository | SCD | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
| 636188 | Ceo-Two (potassium bitartrate 0.9 GM / sodium bicarbonate 0.6 GM) Rectal Suppository | SY | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
| 636185 | K+ bitartrate 900 MG / NaHCO3 600 MG Rectal Suppository | SY | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
| 636188 | K+ bitartrate 900 MG / NaHCO3 600 MG Rectal Suppository [Ceo-Two] | SY | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
| 636185 | Pot bitartrate 900 MG / NaHCO3 600 MG Rectal Suppository | SY | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
| 636188 | Pot bitartrate 900 MG / NaHCO3 600 MG Rectal Suppository [Ceo-Two] | SY | 08670636-5795-4db0-e063-6294a90afa4b | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 0283-1023-00 | 00283102300 | 5.7 g in 1 DOSE PACK | 5.7 g | Historical | |||
| 0283-1023-02 | 00283102302 | 2 DOSE PACK in 1 BOX (0283-1023-02) / 5.7 g in 1 DOSE PACK (0283-1023-00) | 2 dose pack | 2023-10-15 | No | No | Current |
| 0283-1023-36 | 00283102336 | 6 DOSE PACK in 1 BOX (0283-1023-36) / 5.7 g in 1 DOSE PACK (0283-1023-00) | 6 dose pack | 2023-10-15 | No | No | Current |
| 0283-1023-54 | 00283102354 | 54 DOSE PACK in 1 BOX (0283-1023-54) / 5.7 g in 1 DOSE PACK (0283-1023-00) | 54 dose pack | 2023-10-15 | No | No | Current |